4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-022854
CHIEF COMMERCIAL OFFICER sold 68,506 shares at an average $26.12 ($1,789,190)
- CHIEF COMMERCIAL OFFICER acquired 73,589 shares (option exercise)
- CHIEF COMMERCIAL OFFICER gave up 1,738 shares (to pay taxes)
- CHIEF COMMERCIAL OFFICER acquired 211 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-07-15 | Grant or award 10b5-1 | +211 | $15.65 | $3,302 | 18,391 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-01 | Option exercise 10b5-1 | +4,089 | 22,480 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-01 | Shares withheld for taxes 10b5-1 | −1,393 | $26.74 | $37,249 | 21,087 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-02 | Option exercise 10b5-1 | +994 | 22,081 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-02 | Shares withheld for taxes 10b5-1 | −345 | $26.74 | $9,225 | 21,736 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-03 | Option exercise 10b5-1 | +14,000 | $8.83 | $123,620 | 35,736 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-03 | Option exercise 10b5-1 | +29,730 | $11.10 | $330,003 | 65,466 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-03 | Option exercise 10b5-1 | +24,776 | $11.97 | $296,569 | 90,242 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-03 | Sale 10b5-1 | −67,346 | $26.10 | $1,757,731 | 22,896 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-03 | Sale 10b5-1 | −1,160 | $27.12 | $31,459 | 21,736 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-01 | Grant or award · Restricted Share Unit 10b5-1 | +6,962 | 6,962 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-01 | Grant or award · Share Option 10b5-1 | +36,100 | 36,100 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-01 | Option exercise · Restricted Share Unit 10b5-1 | −2,477 | 4,954 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-01 | Option exercise · Restricted Share Unit 10b5-1 | −1,612 | 4,833 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-02 | Option exercise · Restricted Share Unit 10b5-1 | −994 | 994 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-03 | Option exercise · Share Option 10b5-1 | −14,000 | 0 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-03 | Option exercise · Share Option 10b5-1 | −29,730 | 18,534 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-09-03 | Option exercise · Share Option 10b5-1 | −24,776 | 30,924 | D | ||
| Open-market sales · 68,506 sh · avg $26.12 · $1,789,190 | |||||||
Loading xslF345X05/form4-09052024_120928.xml…